Latest News


Neuroscience

New research to capture those with frailty.

A $3-million research grant will help develop technology to identify frailty in older people in hospital, a crucial step towards improving care and long-term patient outcomes. The Kolling Institute’s Professor Sarah Hilmer will lead the large-scale study involving hospitals and universities across Australia as well as international investigators. Professor Hilmer said the five-year project will dev.....
Read more

Category: Funding support, Research Excellence

Kolling Research Symposium 2024.

We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop a unique wellbeing index. Researche.....
Read more

Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Presentations, Research Excellence

Kolling NEWS .

Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There's a focus too on the first steps towards gene therapy for Meniere's disease, the latest research into treatments for dementia and.....
Read more

Category: New Treatment, Newsletters, Research Excellence

Innovation at the Kolling’s core.

In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who come to our hospitals for treatment.” The Kolling .....
Read more

Category: Research Excellence

Crucial steps towards gene therapy for debilitating Meniere’s disease.

Our researchers at the Kolling Institute are at the forefront of Meniere’s disease science developing the first humanised model of the disease ahead of gene therapy. The specialised team is led by world-leading Meniere’s disease researcher and neuroscientist Professor Jose Antonio Lopez-Escamez who relocated from Spain to the institute to pursue his ground-breaking work. His talented team of seven .....
Read more

Category: Neuroscience and Pain Research, Research Excellence, World-leading technology

Special Research Feature.

Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute. Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders. Our teams have continued to increase their research impact, while forging.....
Read more

Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence

World first research to develop cognitive impairment guidelines after spinal cord injury.

A team of researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research has launched a study to develop the first internationally accepted guidelines for assessing cognitive function after a spinal cord injury. The latest data indicates that over 15 million people globally live with a spinal cord injury, and in Australia, there are over 20,000 people living with the injury......
Read more

Category: Neuroscience and Pain Research, Research Excellence

Vale John Walsh.

It is with great sadness that the Kolling Institute acknowledges the passing of Professor John Walsh AO. Professor Walsh had a longstanding relationship with many researchers across the Kolling and the local health district and was immensely respected by his colleagues. Having a background as an actuary, Professor Walsh applied his expertise to many projects over his life, specifically policy devel.....
Read more

Category: Research Excellence

Kolling Institute researchers instrumental in Australian first guidelines .

It has taken three years and many hours of careful work, but two researchers from the John Walsh Centre for Rehabilitation Research have developed the first clinical practice guidelines for physiotherapists to inform the care of people with life-changing spinal cord injuries. Physiotherapy is a key part of rehabilitation for people with a spinal cord injury, but until now, there has been no nationa.....
Read more

Category: Neuroscience and Pain Research, New Treatment, Research Excellence

Professor Michael Cousins leaves extraordinary legacy.

We would like to acknowledge the remarkable life of pain medicine pioneer and former Royal North Shore Hospital specialist Professor Michael Cousins AO who has sadly passed away. Michael was a trailblazer in anaesthesia and pain medicine, and a mentor to many at the Kolling Institute and on the Royal North Shore Hospital campus. With a career spanning more than 50 years, Michael dedicated his life .....
Read more

Category: Research Excellence